Skip to content

    Recently Viewed



      5 things to know about how Johnson & Johnson is helping kids with intestinal worms

      For World Neglected Tropical Diseases Day, check out a video highlighting the company’s commitment to caring for children with these common infections across the globe.

      Share Article
      share to

      In 2012, Johnson & Johnson joined other pharmaceutical companies and organizations, including the Bill & Melinda Gates Foundation, to endorse the London Declaration on Neglected Tropical Diseases (NTDs). As part of this commitment, companies pledged to donate existing treatments—such as mebendazole, Johnson & Johnson’s medicine for soil-transmitted helminths (STH), or intestinal worm infections—and develop new tools to help combat these infections.

      STH infections are among the most common infections around the globe and result from being exposed to contaminated soil, food or water in areas with poor sanitation. Children are particularly vulnerable to the infection, which can lead to malnutrition, stunted growth and even impaired cognitive development.

      To help protect kids ages 1 and older against the infection, the Janssen Pharmaceutical Companies of Johnson & Johnson developed a chewable formulation of mebendazole that, when mixed with a small amount of water, turns into a soft mass and is easier for very young children to swallow.

      Ten years after the landmark London Declaration, here’s a look at how the company is ensuring that mebendazole is accessible to those who need it.

      5 Things to Know About How Johnson & Johnson is Helping Kids With Intestinal Worms

      Johnson & Johnson aims to advance health around the world

      Read about more ways the company is helping to solve complex global health challenges, from HIV to Ebola.

      More from Johnson & Johnson

      Health & wellness
      3D human heart anatomy illustrations

      Do you know what heart failure is? (Hint: It’s probably not what you think)

      For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.